20
total announcements
VAISHALI.NS · 15 min delayed
Vaishali Pharma Limited
Vaishali Pharma Limited has received listing approval from the National Stock Exchange of India Limited for 45,37,865 equity shares allotted on a preferential basis.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange about a newspaper publication related to a public notice regarding a property dispute and a notice of the 19th Annual General Meeting.
Vaishali Pharma Limited
Vaishali Pharma Limited has announced a book closure for its 19th Annual General Meeting (AGM) from September 18-24, 2026, with e-voting to be held from September 21-23, 2026.
Vaishali Pharma Limited
Vaishali Pharma Limited has announced the record date for its 19th Annual General Meeting, which will be held on September 24, 2026. The record date is September 17, 2026, and the company will provide electronic voting facilities for its members.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 24, 2026. The meeting will be held through Video Conferencing and Other Audio-Visual Means (VC/OAVM). The Registered Office of the Company shall be deemed to be the venue for the AGM.
Vaishali Pharma Limited
Vaishali Pharma Limited has published an advertisement in newspapers for its un-audited financial results for the first quarter ended June 30, 2026, as per SEBI listing regulations.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange about the resignation of a Director/KMP/SMP.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange about the resignation of a Director/KMP/SMP.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange about the resignation of a Director/KMP/SMP, but no further details are provided.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange regarding the resignation of Bhaveshkumar Popatlal Upadhyay as Non-Executive Independent Director of the company with effect from August 14, 2026.
Vaishali Pharma Limited
Vaishali Pharma Limited has submitted its unaudited financial results for the first quarter ended June 30, 2026, along with a limited review report. The board of directors has also approved the annual report and director's report for the financial year 2025-26, and convened the 19th Annual General Meeting to be held on September 24, 2026.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange about Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming that the said regulation is not applicable to the company for the quarter ended on 30th June 2026.
Vaishali Pharma Limited
Vaishali Pharma Limited has held a board meeting on July 08, 2026, but no specific outcomes or decisions have been disclosed.
Vaishali Pharma Limited
Vaishali Pharma Limited has submitted the Exchange a copy Scrutinizer's report of Postal Ballot. The company has informed the Exchange regarding voting results for the re-appointment of Mr. Pratik Vikram Jakhelia, Mr. Atul Arvind Vasani, and Mrs. Jagruti Vasani as Independent Director, Managing Director, and Whole-Time Director respectively. All resolutions were passed with over 99% approval.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange about the allotment of 45,37,865 equity shares at an issue price of Rs. 20 per share on a preferential basis to Kesar Pharma Limited for consideration other than cash, as discharge of the non-cash consideration for the subscription of 26.95% of the proposed total issued, subscribed and paid-up equity share capital of Kesar Pharma Limited.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange regarding allotment of 45,37,865 securities pursuant to Preferential Issue at its meeting held on July 03, 2026.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange regarding Outcome of Board Meeting held on July 02, 2026. The Board has approved an increase in Authorised Share Capital from INR. 27,00,00,000 to INR. 29,00,00,000, and deferred the proposal relating to the Issue and Allotment of 61,23,000 equity shares.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, due to consideration of Un-audited Financial Result for the First Quarter Ended 30th June, 2026.
Vaishali Pharma Limited
Vaishali Pharma Limited has been asked by the NSE to clarify its financial results for the quarter ended 31-Mar-2026, specifically regarding the non-submission of the consolidated statement of cash flow.
Vaishali Pharma Limited
Vaishali Pharma Limited has informed the Exchange about General Updates, clarifying the consideration for the issuance of up to 61,23,000 equity shares to Kesar Pharma Limited, ensuring alignment with the valuation determined by the Registered Valuer.